|
FZD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.606200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.630800E-04 |
| Normal-vs-Stage2 |
9.770400E-01 |
| Normal-vs-Stage3 |
1.064150E-02 |
| Normal-vs-Stage4 |
7.389900E-02 |
| Stage1-vs-Stage2 |
1.675860E-02 |
| Stage1-vs-Stage3 |
6.706800E-01 |
| Stage1-vs-Stage4 |
2.357800E-01 |
| Stage2-vs-Stage3 |
6.988500E-02 |
| Stage2-vs-Stage4 |
1.904410E-01 |
| Stage3-vs-Stage4 |
5.165000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.186090E-04 |
| Normal-vs-AfricanAmerican |
4.565600E-02 |
| Normal-vs-Asian |
7.637800E-03 |
| Caucasian-vs-AfricanAmerican |
8.754400E-01 |
| Caucasian-vs-Asian |
9.314400E-01 |
| AfricanAmerican-vs-Asian |
9.285800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.351700E-02 |
| Normal-vs-Female |
4.188600E-04 |
| Male-vs-Female |
3.087800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.50820000000596E-05 |
| Normal-vs-Age(41-60Yrs) |
5.319000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.135400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.890400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.338000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.528030E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.873900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.773620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.621000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.805000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.487200E-01 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
2.532200E-01 |
| Classical-VS-Normal |
1.50610000027029E-07 |
| Tall-VS-Follicular |
4.67420000005436E-06 |
| Tall-VS-Other |
3.797000E-01 |
| Tall-VS-Normal |
1.659990E-02 |
| Follicular-VS-Other |
1.103240E-01 |
| Follicular-VS-Normal |
1.160110E-02 |
| Other-VS-Normal |
5.657800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.558210E-01 |
| Normal-vs-N1 |
5.336300E-02 |
| N0-vs-N1 |
3.796000E-01 |
|
|
